Skip to content

Hoffie.net

  • Beauty & Balance
  • Health News
  • Wellness
  • Online

Home » Magenta

Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate Magenta’s MGTA-145 for Mobilizing and Collecting Stem Cells in Adults and Adolescents with Sickle Cell Disease

December 6, 2020 Health News Comments Off on Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate Magenta’s MGTA-145 for Mobilizing and Collecting Stem Cells in Adults and Adolescents with Sickle Cell Disease
Recent Posts
  • Football linked to more brain damage beyond white matter marks
  • Digital health algorithm drastically cuts antibiotic use in Tanzanian children
  • Have yourself a food-safe Christmas
  • Rapidly increasing COVID-19 subvariant JN.1 dominating the Northeast US
  • Study reveals cytoglobin's pivotal role in cilia movement and organ positioning during development
Copyright © 2025
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok